金沙官网
                       International Cooperation

 

● Covance
 

● RaQualia Pharma Inc.

 


                       CRO

                           XuanZhu Pharma has established a long-term cooperative relationship with a number of well-known CRO companies in 
                           various research fields,including compound synthesis, selection and assessment, preclinical toxicology studies and clinical research:

● WuXi AppTec Co., Ltd.
 

● Shanghai Chempartner Co., Ltd.
 

● Medicilon/MPI Preclinical Research Shanghai
 

● -4166.金沙登录Pharmaron (Beijing) Limited Co., Ltd.
 

● BioDuro (Beijing) Co., Ltd.

● XBL-China

● Zhonglian (Beijing) Pharmaceutical Technology Co., Ltd.

● Research Institute for Liver diseases (shanghai)

● JOINN Laboratories , Inc.

● HD Biosciences (shanghai) Co., Ltd.

 



Domestic universities and research institutes

                           
                         Tsinghua University,Peking University,Shandong University, China Pharmaceutical University, Academy of Military Sciences, Institute of Materia Medica of
                          Chinese Academy of Sciences,Peking Union Medical College Hospital,Tianjin Institute of Pharmaceutical Research, National Shanghai Center for New
                          Drug -9822.com
Safety Evaluation & Research and Shanghai Institute of Materia Medica, etc. -金沙官网-金沙9001官网
 

 
ShanDong XuanZhu welcomes variety of business opportunities: partnership, in-license, out-license, and research collaboration. Should you have any requests, please contact business development division via bd@xuanzhupharm.com
 

Email | Terms of Use | | Contact us |
Copyright © 2014 Sihuan Pharmaceutical Holdings Group Ltd. All rights reserved 鲁ICP备09030169号

4166.金沙登录 轩竹微信民众号